导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -6.12% | 2266/2643 |
| 近一周 | 3.38% | 619/2752 |
| 近一月 | 2.79% | 2408/2723 |
| 近一季 | -5.27% | 2122/2605 |
| 近半年 | -6.08% | 1550/2445 |
| 近一年 | -17.28% | 1555/2194 |
| 近两年 | -17.83% | 1302/1816 |
| 近三年 | -35.69% | 1099/1167 |
| 成立以来 | 54.78% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2023 | -11.86% 1429/2655 |
-0.69% 1818/2280 |
-7.62% 1875/2385 |
-1.89% 593/2515 |
-2.07% 420/2655 |
| 2022 | -20.50% 974/2208 |
-13.64% 804/1919 |
0.25% 1571/2016 |
-15.87% 1360/2113 |
9.14% 237/2208 |
| 2021 | -11.22% 1106/1822 |
-3.32% 800/1255 |
12.64% 322/1330 |
-14.10% 1362/1466 |
-5.10% 1505/1822 |
| 2020 | 62.23% 114/1246 |
8.95% 29/1028 |
29.49% 73/1067 |
6.12% 872/1164 |
8.36% 677/1184 |
| 2019 | 41.96% 226/1092 |
27.91% 331/754 |
-4.87% 442/804 |
9.68% 53/850 |
6.38% 616/918 |
| 2018 | -22.85% 261/834 |
- - |
- - |
- - |
-18.98% 661/691 |
| 2017 | 12.50% 273/714 |
- - |
- - |
- - |
- - |
| 2016 | -13.55% 324/605 |
- - |
- - |
- - |
- - |
| 2015 | 43.93% 36/575 |
- - |
- - |
- - |
- - |
| 2014 | 3.84% 228/237 |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 同泰恒利纯债A | 1.8061 | 73.47% |
| 同泰恒利纯债C | 1.8219 | 73.39% |
| 泰达转型 | 2.1790 | 31.28% |
| 鹏华弘鑫A | 1.2651 | 27.32% |
| 鹏华弘鑫C | 1.2489 | 27.30% |
| 诺安积极回报 | 1.9020 | 27.10% |
| 诺安积极回报C | 2.0130 | 26.95% |
| 东财数字经济混合发起式A | 0.9111 | 23.39% |
| 东财数字经济混合发起式C | 0.8955 | 23.15% |
| 泰达宏利景气领航两年持有混合 | 0.6503 | 22.25% |
| 国泰医药 VS. () |
| 国泰医药 VS. () |